Kinnevik Ab Publ

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Recursion Pharmaceuticals, Inc.
RXRX
$103.74M3.8110.41M0%+$0100
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.